Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Unhealthiest Countries in Europe

In this article, we will be taking a look at the 15 unhealthiest countries in Europe. You can also skip our detailed analysis on the global health market and directly head to the 5 Unhealthiest Countries in Europe.

Healthcare Market Growth and Projections: Global and European Trends Through 2040

In 2023, the healthcare services sector was valued at approximately $7.975 trillion, an increase from $7.5 trillion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 6.3% until 2027, reaching $9.8 trillion. This market includes various segments such as hospitals, digital health, and healthcare services. Specifically, the hospital market is expected to grow annually by 4.18% from 2024 to 2029, with its market volume anticipated to reach $5.19 trillion by 2029.

The digital health market in Europe is experiencing significant growth. It was valued at USD 66.2 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 22.3% from 2024 to 2030, reaching USD 267.2 billion by 2030, as reported by Grand View Research. The hospital market in Europe is another critical component, projected to reach a revenue of USD 0.96 trillion in 2024, with an annual growth rate of 3.68% from 2024 to 2029. This market includes general, psychiatric, and specialist hospitals, providing a range of medical and surgical services.  In 2020, curative and rehabilitative care services accounted for more than half of the current healthcare expenditure in most EU Member States. Medical goods were the second-largest expenditure category, accounting for 18.2% of healthcare spending.

By 2040, it is expected that a higher proportion of healthcare funds will be allocated to health promotion and illness prevention, potentially reducing healthcare spending by nearly €250 billion in 2030 and close to €595 billion by 2040.

Key Players in the Global Health Market 

Companies like AstraZeneca PLC (NYSE:AZN), Novo Nordisk A/S (NYSE:NVO), and Sanofi, among others, play a vital role in the global health market. For example, CVS Health Corporation (NYSE:CVS) has invested over $3 million in Phoenix to enhance health outcomes by increasing equitable access to care and addressing social determinants of health. The company has also committed to supporting mental health services by awarding a $100,000 grant to the Phoenix Indian Center.

AstraZeneca PLC (NYSE:AZN) is a science-led, patient-focused biopharmaceutical company that operates in over 100 countries worldwide. AstraZeneca has made significant progress in global healthcare access, aiming to reach 50 million people by 2025. As of December 2023, the company has already reached 66.4 million individuals through its initiatives and trained 127,384 healthcare workers to enhance capabilities. AstraZeneca is part of the Partnership for Health System Sustainability and Resilience (PHSSR), active in over 30 countries. Its Healthy Heart Africa program achieved its goal of screening 10 million people for hypertension by 2024, one year ahead of the 2025 target. Financially, in May 2024, AstraZeneca announced plans to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing its global ADC supply. AstraZeneca PLC (NYSE:AZN) also completed the acquisition of Fusion Pharmaceuticals Inc. in June, aiming to advance cancer treatment by introducing targeted therapies. For H1 2024, AstraZeneca reported total revenue of $25.6 billion, an 18% increase, with strong growth across all therapeutic areas, particularly Oncology, CVRM, and R&I, each up 22%. The core operating margin was 33%, with core earnings per share rising 5% to $4.03. An interim dividend of $1.00 was declared, and the FY 2024 guidance was upgraded, anticipating mid-teens revenue and core EPS growth at constant exchange rates.

Similarly, Novo Nordisk A/S (NYSE:NVO) is also one of the biggest European Healthcare Companies. Novo Nordisk’s primary mission is to drive change in defeating serious chronic diseases, with a particular emphasis on its heritage in diabetes treatment. In Q2 2024, Novo Nordisk reported sales of $9.67 billion, a 25% increase from the previous year, but below the Zacks Consensus Estimate of $9.91 billion. Earnings per American Depositary Receipt (ADR) were 65 cents, missing the consensus estimate of 71 cents. Net profit reached $2.89 billion, lower than the LSEG forecast of $20.9 billion, and EBIT was 25.93 billion Danish kroner, below the expected 26.86 billion kroner. GLP-1 sales constituted 75% of Q2 revenues, driven by growth in Diabetes and Obesity Care, despite a slight decline in Rare Disease sales. CEO Lars Fruergaaard Jørgensen expressed satisfaction with the sales growth and announced an increase in full-year guidance for Novo Nordisk A/S (NYSE:NVO).

While we acknowledge the potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TSLA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ ALSO: 25 Best U.S. Cities for Retirement Healthcare and Top 20 Largest Publicly Traded Healthcare Companies.

Pixabay/Public Domain

Our Methodology 

For our list, we looked at two indexes: the GHS index of 2021 and the health pillar of Legatum Prosperity index of 2023. The 2021 Global Health Security (GHS) Index assesses 195 countries’ preparedness for epidemics and pandemics across six categories. The global average score is 38.9, indicating weak international readiness despite COVID-19 efforts. Similarly, The Health pillar of the 2023 Legatum Prosperity Index assesses health outcomes, systems, risk factors, and mortality rates, highlighting the importance of physical and mental health and access to effective healthcare services for individual and national prosperity. Hence, we averaged the scores of GHS, and the health pillar’s from Legatum index and the final rankings in our list were adjusted according to the average we obtained of these scores.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Here is our list of the 15 unhealthiest countries in Europe.

15. Belarus  

Insider Monkey Score: 14.5

Belarus tops the list for being the unhealthiest country in Europe. Belarus also ranks high in both alcohol and tobacco consumption.  The lifestyle choices of Belarusians, including diet and physical inactivity, contribute significantly to the country’s health challenges. In 2023, Belarus’ healthcare spending rose by 116% from the previous year, reaching a minimum standard of $408.70 per person, up from $351.50 in 2022. This increase, driven by the DRG model for result-based budgeting, allowed the reallocation of over $800,000 to cover inpatient care costs in Grodno.

14. Lithuania  

Insider Monkey Score: 14

Lithuania has one of the highest alcohol consumption rates in the world. On average, Lithuanians consume 18.2 liters of alcohol per person annually, which places the country among the top consumers globally. In 2021, Lithuania spent 7.85% of GDP on health, up from 6% since 2008. In 2022, spending decreased slightly to 7.5% of GDP.

13. Bulgaria  

Insider Monkey Score: 12

Unhealthy diets and low levels of physical activity contribute to health issues in Bulgaria. Although obesity rates in Bulgaria are below the EU average, they are still considerable, with 26.3% of adult women and 28.3% of adult men living with obesity. In 2023, Bulgaria’s draft healthcare budget exceeds $5 billion. The National Health Insurance Fund allocated $4.07 billion, including $248 million for primary care, $250 million for specialized care, $148 million for dental care, $1.843 billion for hospital care, $97 million for medical and diagnostic activities, $946 million for medicines and medical devices, and $500 million for access and health needs.

12. Romania  

Insider Monkey Score: 9

Romania ranks among the top countries in Europe with unhealthy diets, which can lead to various health issues despite the lower obesity rate. In 2021, Romania’s health spending was $16.7 billion, or $2,385 per person, accounting for 5.69% of GDP, one of the lowest rates in the EU. The public sector predominantly provides healthcare, covering nearly all citizens, with 79.5% of spending publicly financed, similar to the EU average. However, Romania’s health system is underfunded, leading to common out-of-pocket expenses, especially for dental care and pharmaceuticals.

11. Bosnia and Herzegovina  

Insider Monkey Score: 8.5

Noncommunicable diseases are the leading cause of death and disability in Bosnia and Herzegovina, accounting for approximately 80% of annual deaths. The most prevalent NCDs include heart disease, stroke, cancer, diabetes, and chronic respiratory diseases. In 2020, Bosnia and Herzegovina spent 9.7% of GDP on health, above both the regional and income group averages. Public health spending slightly increased from 6.7% in 2013 to 6.9% in 2020, while private spending, mostly on out-of-pocket payments, remained around 30%, double the EU average.

10. Moldova  

Insider Monkey Score: 8

Moldova has a significant obesity problem, with an obesity rate of 20.6%. In 2024, Moldova’s health expenditure was 7.7% of GDP. Out-of-pocket spending was 29.4% of total health expenditure, and domestic government health spending was 14.6% of general government expenditure.

9. Azerbaijan  

Insider Monkey Score: 8

Azerbaijan faces challenges related to malnutrition, with 35.1% of women aged 15 to 49 years affected by anemia. Additionally, 17.8% of children under five years of age are affected by stunting, and 14.1% are overweight. In 2021, Azerbaijan spent $839 million on healthcare, or 5.2% of the state budget and 1.5% of GDP, a 0.5% increase from 2020.

8. Russia  

Insider Monkey Score: 8

Russia stands eighth among the unhealthiest countries in Europe. Russia has a significant obesity problem, with approximately 30.3% of adults classified as obese, a rate higher than many OECD countries. Noncommunicable diseases (NCDs) such as cardiovascular diseases and diabetes are prevalent in Russia, driven by factors like obesity, hypertension, and inadequate nutrition. The prevalence of hypertension among Russian adults aged 50 and older is estimated to be 69.2%, which is a major risk factor for cardiovascular diseases. In 2023, Russia’s healthcare spending was $138 billion, or 7% of GDP, with $919 per capita, a significant increase from 4.6% of GDP in 2020 due to the COVID-19 pandemic.

7. Armenia 

Insider Monkey Score: 8

Armenia ranks poorly in terms of blood glucose levels, which indicates a high risk of diabetes among its population. Armenia has an obesity rate of 19.5% which is one of the factors that makes the country unhealthy. In 2017, Armenia spent 1.4% of GDP on public health, below both the regional average of 4.9% and its income group’s average of 4%. In 2019, per capita health expenditure was $1,616, higher than the upper middle-income average but lower than the regional average. Armenia also had one of the highest out-of-pocket spending ratios, with 81.4% in 2021.

6. Macedonia  

Insider Monkey Score: 8

North Macedonia has a notable prevalence of obesity, with 23.9% of adult women and 25.1% of adult men classified as obese. This is slightly below the regional average for women but above the average for men. Obesity is a significant risk factor for various non-communicable diseases (NCDs), including diabetes, which affects 7.1% of adult women and 8.4% of adult men in the country. Skopje, the capital city, is frequently listed among the most polluted cities in Europe. In 2018, the levels of PM10 particles exceeded EU limits for 202 days. The World Health Organization estimates that air pollution contributes to around 4,000 premature deaths annually in North Macedonia, with significant economic costs ranging from €570 to €1,470 million.

5. Albania  

Insider Monkey Score: 8

Albania stands fifth among the unhealthiest countries in Europe. Albania has an obesity rate of approximately 24.7%. In 2022, Albania’s public healthcare spending was 63.8 billion lek, or 2.98% of GDP, the lowest percentage since 2017. Despite this, funding for essential services like primary care and drug reimbursement has remained unchanged, with drug reimbursement making up only 1.6% of the 2024 budget.

4. Serbia  

Insider Monkey Score: 5.5

Serbia has a notable prevalence of obesity, with 23.9% of adult women and 23.6% of adult men living with obesity. Serbia shows limited progress towards achieving diet-related NCD targets. Diabetes affects 7.0% of adult women and 8.2% of adult men. The prevalence of overweight children under five years of age is 10.9%, indicating early onset of weight-related health issues. While Serbia is on course to meet several global nutrition targets, challenges remain. For instance, 22.8% of women aged 15 to 49 are affected by anemia, and 5.4% of children under five are stunted, which is higher than the European average. In 2021, Serbia spent 10% of its GDP on health, which is above its income group’s average but below its regional average, amounting to $919 per capita.

3. Ukraine

Insider Monkey Score: 4

In Ukraine, 27.5% of adult women and 24.5% of adult men are classified as obese. This rate is higher than the regional average for women but slightly lower for men. In terms of children, 26.5% of those under five are overweight, which is significantly higher than the European average of 4.5%. Ukraine faces issues with malnutrition, particularly among children. Stunting affects 22.9% of children under five, and 8.2% suffer from wasting. Additionally, 17.7% of women of reproductive age are affected by anemia. In 2024, Ukraine’s health spending is projected to reach UAH 239 billion, an increase of UAH 31 billion from 2023. This budget includes UAH 16 billion for the healthcare guarantee program, UAH 1 billion for hospital construction, and funds for a pilot dental prostheses program for veterans.

2. Georgia 

Insider Monkey Score: 3.5

Georgia stands among the unhealthiest countries in Europe. Georgia has a significant obesity rate, with approximately 37% of its population classified as obese. Georgia’s FY 2025 budget allocates $7.3 billion to the Departments of Behavioral Health and Developmental Disabilities, Community Health, and Public Health, representing about 20% of state spending. Of this, $6.6 billion (90%) comes from General Fund appropriations, with the remaining $740 million from sources like Tobacco Settlement Funds. This represents an 11% increase, or $666 million, over the FY 2024 budget.

1. Montenegro 

Insider Monkey Score: 1

Montenegro has a significant obesity problem, with an obesity rate of 25.6% as of recent data and tops the list for being the unhealthiest country in Europe. The economic impact of overweight and obesity in Montenegro was estimated to be approximately US$173.05 million in 2019, which equates to US$276 per capita and 3.1% of the country’s GDP. Alcohol consumption is also notably high, with Montenegrins consuming an average of 12.8 liters of alcohol annually, which is significantly above the global average of 7 liters per person. Non-communicable diseases (NCDs) account for 95% of all deaths in Montenegro.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure. None: The 15 Unhealthiest Countries in Europe is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…